AI-generated analysis, not investment advice. The articles are written by AI, edited, and checked against company filings — but the judgements are opinions and the figures go stale. How this is made · Terms
Abbott Laboratories (ABT) valuation, revenue & earnings
P/E and P/S history, revenue and growth, ROIC vs. cost of capital, segments, earnings and analyst forecasts
At a glance
Market capitalisation$173B
Moat ratingNarrow moat
ValuationFair
Revenue, and where it comes from$44.33bn in 2025: Medical Devices $21.39bn, Diagnostics $8.94bn, Nutrition $8.45bn, Established Pharma $5.54bn; devices 61.1% of segment operating earnings; latest quarter $12.59bn, +13.0% reported, +4.8% comparable
Recent years are exact, taken from company filings; the earliest years are approximate. Forecast figures are Wall Street consensus, not company guidance. Read the full Abbott Laboratories moat analysis →